# Quoin Pharmaceuticals Ltd.: Form 8-K, filed Aug 20, 2026

- Company: [Quoin Pharmaceuticals Ltd.](/companies/qnrx.md) (CIK 1671502)
- Form: 8-K
- Filed: 2026-08-20
- Accepted by EDGAR: Aug 20, 2026, 16:19 ET
- Period: 2026-08-20
- Accession: 0001104659-26-099239
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671502/000110465926099239/tm2623719d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671502/000110465926099239/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671502/000110465926099239/tm2623719d1_8k.htm

Filed Aug 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-099239. Last ingested by Listed: Nov 4, 2026, 19:41 ET. No prices; not investment advice.